These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Exacerbation of the pathogenesis of the diabetogenic variant of encephalomyocarditis virus in mice by interferon. Gould CL; McMannama KG; Bigley NJ; Giron DJ J Interferon Res; 1985; 5(1):33-7. PubMed ID: 3886808 [TBL] [Abstract][Full Text] [Related]
3. Differing attachment of diabetogenic and nondiabetogenic variants of encephalomyocarditis virus to beta-cells. Kaptur PE; Thomas DC; Giron DJ Diabetes; 1989 Sep; 38(9):1103-8. PubMed ID: 2475377 [TBL] [Abstract][Full Text] [Related]
4. Induction of diabetes by cumulative environmental insults from viruses and chemicals. Toniolo A; Onodera T; Yoon JW; Notkins AL Nature; 1980 Nov; 288(5789):383-5. PubMed ID: 6253833 [TBL] [Abstract][Full Text] [Related]
5. A genetically determined host factor controlling susceptibility to encephalomyocarditis virus-induced diabetes in mice. Kang Y; Yoon JW J Gen Virol; 1993 Jun; 74 ( Pt 6)():1207-13. PubMed ID: 8389806 [TBL] [Abstract][Full Text] [Related]
6. Virus-induced diabetes mellitus. No evidence for immune mechanisms in the destruction of beta-cells by the D-variant of encephalomyocarditis virus. Yoon JW; McClintock PR; Bachurski CJ; Longstreth JD; Notkins AL Diabetes; 1985 Sep; 34(9):922-5. PubMed ID: 2993085 [TBL] [Abstract][Full Text] [Related]
7. Assessment of viral and immune factors in EMC virus-induced diabetes: effects of cyclosporin A and interferon. Vialettes B; Baume D; Charpin C; De Maeyer-Guignard J; Vague P J Clin Lab Immunol; 1983 Jan; 10(1):35-40. PubMed ID: 6186814 [TBL] [Abstract][Full Text] [Related]
8. Identification of antigenic differences between the diabetogenic and non-diabetogenic variants of encephalomyocarditis virus using monoclonal antibodies. Yoon JW; Ko W; Bae YS; Pak CY; Amano K; Eun HM; Kim MK J Gen Virol; 1988 May; 69 ( Pt 5)():1085-90. PubMed ID: 2836552 [TBL] [Abstract][Full Text] [Related]
9. Replication of diabetogenic and nondiabetogenic variants of encephalomyocarditis (EMC) virus in ICR Swiss mice. Gould CL; Trombley ML; Bigley NJ; McMannama KG; Giron DJ Proc Soc Exp Biol Med; 1984 Apr; 175(4):449-53. PubMed ID: 6324221 [TBL] [Abstract][Full Text] [Related]
10. A murine model of insulin-dependent diabetes mellitus resulting from the cumulative effects of the nondiabetogenic strain of encephalomyocarditis virus and a single low dose of streptozocin. Blay RA; Bigley NJ; Giron DJ Diabetes; 1985 Dec; 34(12):1288-92. PubMed ID: 2998912 [TBL] [Abstract][Full Text] [Related]
11. The importance of immunologic factors in the pathogenesis of encephalomyocarditis virus induced diabetes in mice. Dafoe DC; Moore CL; Plotkin SA; Naji A; Barker CF Behring Inst Mitt; 1984 Jul; (75):17-25. PubMed ID: 6091611 [TBL] [Abstract][Full Text] [Related]
12. Impaired cytokine response in male ICR Swiss mice after infection with D variant of encephalomyocarditis virus. Bigley NJ; Blay RA; Smith RA Diabetes; 1987 Dec; 36(12):1408-13. PubMed ID: 2824259 [TBL] [Abstract][Full Text] [Related]
13. Alterations in immunological reactivity in encephalomyocarditis virus-induced murine diabetes. I. Defective primary IgM plaque forming cell responses to sheep erythrocytes: correction by islet cell transplantation. Handwerger BS; Fernandes G; Riehm T; Yoon JW; Sutherland DE; Brown DM Clin Exp Immunol; 1985 Apr; 60(1):145-50. PubMed ID: 2988831 [TBL] [Abstract][Full Text] [Related]
14. Virus-induced diabetes mellitus. IV. Genetic and environmental factors influencing the development of diabetes after infection with the M variant of encephalomyocarditis virus. Ross ME; Onodera T; Brown KS; Notkins AL Diabetes; 1976 Mar; 25(3):190-7. PubMed ID: 176076 [TBL] [Abstract][Full Text] [Related]
16. Prodromal immune manifestations in EMC-M virus induced diabetes: islet bound and circulating antibodies, and changes in lymphocyte subsets. Buschard K; Rygaard J; Lund E; Röpke C Diabetes Res; 1987 Jun; 5(2):67-72. PubMed ID: 2820645 [TBL] [Abstract][Full Text] [Related]
17. Trypanosoma brucei rhodesiense infection in mice prevents virus-induced diabetes: possible role of interferon and immunological mechanisms. Gould CL; De Gee AL; Mansfield JM; Sonnenfeld G J Interferon Res; 1986 Oct; 6(5):499-506. PubMed ID: 2433362 [TBL] [Abstract][Full Text] [Related]
18. Protective effects of macrophage-derived interferon against encephalomyocarditis virus-induced diabetes mellitus in mice. Hirasawa K; Ogiso Y; Takeda M; Lee MJ; Itagaki S; Doi K Lab Anim Sci; 1995 Dec; 45(6):652-6. PubMed ID: 8746525 [TBL] [Abstract][Full Text] [Related]
19. Altered pathogenesis in encephalomyocarditis virus (D variant)-infected diabetes-susceptible and resistant strains of mice. Gaines KL; Kayes SG; Wilson GL Diabetologia; 1986 May; 29(5):313-20. PubMed ID: 3013707 [TBL] [Abstract][Full Text] [Related]
20. Effect of interferons and poly(I):poly(C) on the pathogenesis of the diabetogenic variant of encephalomyocarditis virus in different mouse strains. Giron DJ; Agostini HJ; Thomas DC J Interferon Res; 1988 Dec; 8(6):745-53. PubMed ID: 2466089 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]